Ellagic Acid
Internal ID | da6c27ef-4f9c-4c3c-941b-79e898ad10bc |
Taxonomy | Phenylpropanoids and polyketides > Tannins > Hydrolyzable tannins |
IUPAC Name | 6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione |
SMILES (Canonical) | C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O |
SMILES (Isomeric) | C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O |
InChI | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H |
InChI Key | AFSDNFLWKVMVRB-UHFFFAOYSA-N |
Popularity | 5,938 references in papers |
Molecular Formula | C14H6O8 |
Molecular Weight | 302.19 g/mol |
Exact Mass | 302.00626715 g/mol |
Topological Polar Surface Area (TPSA) | 134.00 Ų |
XlogP | 1.10 |
Atomic LogP (AlogP) | 1.31 |
H-Bond Acceptor | 8 |
H-Bond Donor | 4 |
Rotatable Bonds | 0 |
476-66-4 |
Benzoaric acid |
Elagostasine |
Lagistase |
Eleagic acid |
Alizarine Yellow |
2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione |
Gallogen |
Llagic acid |
Acido elagico |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8113 | 81.13% |
Caco-2 | - | 0.8901 | 89.01% |
Blood Brain Barrier | - | 0.8250 | 82.50% |
Human oral bioavailability | + | 0.6714 | 67.14% |
Subcellular localzation | Mitochondria | 0.7339 | 73.39% |
OATP2B1 inhibitior | - | 0.6743 | 67.43% |
OATP1B1 inhibitior | + | 0.9414 | 94.14% |
OATP1B3 inhibitior | + | 0.9847 | 98.47% |
MATE1 inhibitior | - | 0.8400 | 84.00% |
OCT2 inhibitior | - | 0.9250 | 92.50% |
BSEP inhibitior | - | 0.9372 | 93.72% |
P-glycoprotein inhibitior | - | 0.9413 | 94.13% |
P-glycoprotein substrate | - | 0.9733 | 97.33% |
CYP3A4 substrate | - | 0.6911 | 69.11% |
CYP2C9 substrate | - | 0.8283 | 82.83% |
CYP2D6 substrate | - | 0.8434 | 84.34% |
CYP3A4 inhibition | - | 0.9078 | 90.78% |
CYP2C9 inhibition | - | 0.5591 | 55.91% |
CYP2C19 inhibition | - | 0.8017 | 80.17% |
CYP2D6 inhibition | - | 0.9575 | 95.75% |
CYP1A2 inhibition | - | 0.5914 | 59.14% |
CYP2C8 inhibition | - | 0.9155 | 91.55% |
CYP inhibitory promiscuity | - | 0.9568 | 95.68% |
UGT catelyzed | + | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.6954 | 69.54% |
Eye corrosion | - | 0.9891 | 98.91% |
Eye irritation | + | 0.9491 | 94.91% |
Skin irritation | + | 0.5543 | 55.43% |
Skin corrosion | - | 0.9457 | 94.57% |
Ames mutagenesis | - | 0.5564 | 55.64% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.8048 | 80.48% |
Micronuclear | + | 0.9200 | 92.00% |
Hepatotoxicity | + | 0.6948 | 69.48% |
skin sensitisation | - | 0.8054 | 80.54% |
Respiratory toxicity | + | 0.5889 | 58.89% |
Reproductive toxicity | + | 0.6333 | 63.33% |
Mitochondrial toxicity | + | 0.7500 | 75.00% |
Nephrotoxicity | - | 0.8449 | 84.49% |
Acute Oral Toxicity (c) | II | 0.6020 | 60.20% |
Estrogen receptor binding | - | 0.5951 | 59.51% |
Androgen receptor binding | + | 0.7235 | 72.35% |
Thyroid receptor binding | - | 0.7062 | 70.62% |
Glucocorticoid receptor binding | + | 0.8374 | 83.74% |
Aromatase binding | + | 0.5259 | 52.59% |
PPAR gamma | + | 0.7337 | 73.37% |
Honey bee toxicity | - | 0.9402 | 94.02% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
Fish aquatic toxicity | + | 0.9531 | 95.31% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] |
891.3 nM 891.3 nM 125.9 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via Super-PRED |
CHEMBL1900 | P15121 | Aldose reductase |
200 nM 200 nM |
IC50 IC50 |
PMID: 22261024
via Super-PRED |
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
5011.9 nM |
Potency |
via CMAUP
|
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
125.9 nM 562.3 nM 223.9 nM 125.9 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via Super-PRED |
CHEMBL4822 | P56817 | Beta-secretase 1 |
3900 nM |
IC50 |
PMID: 24835197
|
CHEMBL1293237 | P54132 | Bloom syndrome protein |
1122 nM 1995.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL261 | P00915 | Carbonic anhydrase I |
2320 nM 68200 nM |
Ki Ki |
PMID: 20185318
PMID: 22892213 |
CHEMBL205 | P00918 | Carbonic anhydrase II |
2180 nM |
Ki |
PMID: 20185318
|
CHEMBL2885 | P07451 | Carbonic anhydrase III |
10500 nM |
Ki |
PMID: 20185318
|
CHEMBL3729 | P22748 | Carbonic anhydrase IV |
9080 nM |
Ki |
PMID: 20185318
|
CHEMBL3594 | Q16790 | Carbonic anhydrase IX |
9370 nM 79800 nM |
Ki Ki |
PMID: 20185318
PMID: 22892213 |
CHEMBL4789 | P35218 | Carbonic anhydrase VA |
7590 nM |
Ki |
PMID: 20185318
|
CHEMBL3969 | Q9Y2D0 | Carbonic anhydrase VB |
12700 nM |
Ki |
PMID: 20185318
|
CHEMBL3025 | P23280 | Carbonic anhydrase VI |
7060 nM |
Ki |
PMID: 20185318
|
CHEMBL2326 | P43166 | Carbonic anhydrase VII |
6320 nM 8790 nM |
Ki Ki |
PMID: 20185318
PMID: 22892213 |
CHEMBL3242 | O43570 | Carbonic anhydrase XII |
10100 nM 8150 nM |
Ki Ki |
PMID: 20185318
PMID: 22892213 |
CHEMBL3912 | Q8N1Q1 | Carbonic anhydrase XIII |
4240 nM |
Ki |
PMID: 22892213
|
CHEMBL3510 | Q9ULX7 | Carbonic anhydrase XIV |
8910 nM |
Ki |
PMID: 20185318
|
CHEMBL3629 | P68400 | Casein kinase II alpha |
40 nM 20 nM |
IC50 Ki |
PMID: 19414254
via Super-PRED |
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
31622.8 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL2392 | P06746 | DNA polymerase beta |
158.5 nM 158.5 nM |
Potency Potency |
via CMAUP
via Super-PRED |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase |
14.1 nM 14.1 nM |
Potency Potency |
via CMAUP
via Super-PRED |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 |
<
1230 nM < 980 nM 980 nM |
IC50 IC50 IC50 |
via CMAUP
via CMAUP via Super-PRED |
CHEMBL4105924 | Q14576 | ELAV-like protein 3 |
600 nM |
IC50 |
via Super-PRED
|
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
3162.3 nM 1584.9 nM 251.2 nM 251.2 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via Super-PRED |
CHEMBL5147 | P54760 | Ephrin type-B receptor 4 |
1830 nM |
IC50 |
PMID: 22377675
|
CHEMBL203 | P00533 | Epidermal growth factor receptor erbB1 |
690 nM 690 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL2409 | P34913 | Epoxide hydratase |
20700 nM |
IC50 |
PMID: 24679441
|
CHEMBL2695 | Q05397 | Focal adhesion kinase 1 |
3110 nM |
IC50 |
PMID: 22377675
|
CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 |
100 nM 100 nM |
IC50 IC50 |
PMID: 24900447
via Super-PRED |
CHEMBL262 | P49841 | Glycogen synthase kinase-3 beta |
7500 nM |
IC50 |
PMID: 16610779
|
CHEMBL5460 | P0DMV8 | Heat shock 70 kDa protein 1 |
760 nM |
IC50 |
via CMAUP
|
CHEMBL4331 | P68871 | Hemoglobin beta chain |
10000 nM |
Potency |
via CMAUP
|
CHEMBL3717 | P08581 | Hepatocyte growth factor receptor |
580 nM 580 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1293299 | Q03164 | Histone-lysine N-methyltransferase MLL |
11220.2 nM |
Potency |
via CMAUP
|
CHEMBL1981 | P06213 | Insulin receptor |
340 nM 340 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1957 | P08069 | Insulin-like growth factor I receptor |
250 nM 250 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
7079.5 nM 794.3 nM 2511.9 nM 794.3 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via Super-PRED |
CHEMBL2608 | P10253 | Lysosomal alpha-glucosidase |
4466.8 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
19952.6 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
19952.6 nM 15848.9 nM 31622.8 nM 12589.3 nM 14125.4 nM 22387.2 nM 39810.7 nM 35481.3 nM |
Potency Potency Potency Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL4899 | P41279 | Mitogen-activated protein kinase kinase kinase 8 |
2370 nM |
IC50 |
PMID: 22377675
|
CHEMBL1293258 | P84022 | Mothers against decapentaplegic homolog 3 |
142 nM 142 nM |
IC50 IC50 |
via CMAUP
via Super-PRED |
CHEMBL5784 | O60285 | NUAK family SNF1-like kinase 1 |
510 nM 510 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1913 | P09619 | Platelet-derived growth factor receptor beta |
1300 nM |
IC50 |
PMID: 22377675
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
3981.1 nM |
Potency |
via CMAUP
|
CHEMBL1824 | P04626 | Receptor protein-tyrosine kinase erbB-2 |
3540 nM |
IC50 |
PMID: 22377675
|
CHEMBL3797 | Q13315 | Serine-protein kinase ATM |
19952.6 nM |
Potency |
via CMAUP
|
CHEMBL4282 | P31749 | Serine/threonine-protein kinase AKT |
3340 nM |
IC50 |
PMID: 22377675
|
CHEMBL4722 | O14965 | Serine/threonine-protein kinase Aurora-A |
2480 nM |
IC50 |
PMID: 22377675
|
CHEMBL2185 | Q96GD4 | Serine/threonine-protein kinase Aurora-B |
2500 nM |
IC50 |
PMID: 22377675
|
CHEMBL5145 | P15056 | Serine/threonine-protein kinase B-raf |
1760 nM |
IC50 |
PMID: 22377675
|
CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 |
3340 nM |
IC50 |
PMID: 22377675
|
CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 |
2970 nM |
IC50 |
PMID: 22377675
|
CHEMBL1641347 | Q4U2R8 | Solute carrier family 22 member 6 |
270 nM |
IC50 |
PMID: 15870380
|
CHEMBL1947 | P10828 | Thyroid hormone receptor beta-1 |
39810.7 nM 25118.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL267 | P12931 | Tyrosine-protein kinase SRC |
300 nM 800 nM 800 nM |
IC50 IC50 IC50 |
PMID: 7518523
PMID: 22377675 via Super-PRED |
CHEMBL4128 | Q02763 | Tyrosine-protein kinase TIE-2 |
260 nM 260 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
70.8 nM 50.1 nM 100 nM 50.1 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via Super-PRED |
CHEMBL1293227 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 |
1122 nM |
Potency |
via CMAUP
|
CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 |
790 nM 790 nM |
IC50 IC50 |
PMID: 22377675
via Super-PRED |
CHEMBL1955 | P35916 | Vascular endothelial growth factor receptor 3 |
1540 nM |
IC50 |
PMID: 22377675
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.27% | 95.56% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 90.09% | 91.49% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 89.73% | 89.00% |
CHEMBL1163101 | O75460 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 85.75% | 98.11% |
CHEMBL3194 | P02766 | Transthyretin | 85.72% | 90.71% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 83.24% | 99.15% |
CHEMBL3401 | O75469 | Pregnane X receptor | 82.94% | 94.73% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 82.77% | 94.45% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 80.68% | 99.23% |
CHEMBL2581 | P07339 | Cathepsin D | 80.21% | 98.95% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 5281855 |
NPASS | NPC178134 |
ChEMBL | CHEMBL6246 |
LOTUS | LTS0037297 |
wikiData | Q422044 |